The influence of age, gender, insulin dose, BMI, and blood pressure on metabolic control in young patients with type 1 diabetes

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 16, Iss. 8, 2015-12 ,pp. : 581-586

John Wiley & Sons Inc

Access to resources Recommend Favorite

Single‐dose new insulin glargine 300 U/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 3, 2015-03 ,pp. : 254-260

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin

By McAdam-Marx Carrie   Yu Junhua   Bouchard Jonathan   Aagren Mark   Brixner Diana I.  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 191-201

Informa Healthcare

Access to resources Recommend Favorite

An economic assessment of analogue basal–bolus insulin versus human basal–bolus insulin in subjects with type 1 diabetes in the UK

By Palmer Andrew J.   Valentine William J.   Ray Joshua A.   Foos Volker   Lurati Francesco   Smith Inger   Lammert Morten   Roze Stéphane  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 895-901

Informa Healthcare

Access to resources Recommend Favorite

Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal–bolus regimens: insights from the PREDICTIVE study

By Hermansen Kjeld   Dornhorst Anne   Sreenan Seamus  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2601-2608

Informa Healthcare

Access to resources Recommend Favorite